The Tegel PDS does highlight EBITDA CAGR of 12.7% for FY13-FY17. This is pretty much in-line with RBD over the same period. This growth has occurred during the ownership of private equity (rather than a listed entity). Top line growth is at around 7%. RBD will grow the top line faster. However, this includes that Australian acquisition.
I use Net Debt/EBITDA to measure balance sheet strength:
TGH = 1.42
RBD= 1.09
RBD has less leverage. However, the debt for Tegel is still at acceptable levels. RBD should be able to use their balance sheet to acquire further Australian assets without having to come back to shareholders.